Eyal Sandach

Neovasc, Inc. engages in the development, manufacture and marketing of medical devices. It focuses on Neovast Tiara and Neovasc Reducer products. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.

B-Balloon Ltd. develops devices used to treat ostial and bifurcation lesions in coronary and peripheral arteries. The company is based in Or Yehuda, Israel. B-Balloon was acquired by Medical Ventures Corp. from Peregrine Ventures Management Ltd. on July 02, 2008 for $27.17 million.

Astora Women's Health, Inc. engages in the provision of pelvic health solutions. The company was founded by Dr. Brantley Scott in 1972 and is headquartered in Minnetonka, MN.

Innovea Medical Ltd. develops software solutions for medical images, empower radiologists, and cardiologists. The firm’s flagship product Lumine integrates within the radiologist's workstation to enhance the conspicuity of blood vessels in low-attenuation CT images. The company was founded in 2006 by Adi Mashiach and is headquartered in Ramat Gan, Israel.

FEMSelect Ltd. develops solution for treatment of pelvic organ prolapse repair. Its products NeuGuide is an anchoring system for the treatment of uterine prolapse. The company was founded by Eyal Sandach, Menahem Neuman and Boaz Harari in 2010 and is headquartered in Ramat Hachayal, Israel.

Medical Ventures Corp. develops, manufactures and distributes medical devices and is focused on the development and commercialization of medical devices which clearly address a clinical need in the cardiovascular marketplace. The Company has two divisions: PMD tissue products used in cardiac reconstruction and repair and Angiometrx catheter products for the rapidly growing interventional cardiology market. The focus in both divisions is the commercialization of the cardiovascular medical devices currently in the MEV’s product portfolio and the development of new products based upon these two core technologies. The company is located in Richmond, Canada.

Neovasc Medical Ltd. develops medical devices for the treatment of refractory angina. It offers minimally invasive treatment for Ischemic heart disease. The company was founded in 2002 by Boaz Lifschitz and is headquartered in Or Yehuda, Israel